Trials / Completed
CompletedNCT02847624
Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,802 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) in the real world clinical setting in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tolvaptan |
Timeline
- Start date
- 2014-03-24
- Primary completion
- 2022-09-20
- Completion
- 2022-09-20
- First posted
- 2016-07-28
- Last updated
- 2025-12-10
- Results posted
- 2025-12-10
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02847624. Inclusion in this directory is not an endorsement.